Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VEMLIDY safely and effectively. See full prescribing information for VEMLIDY. VEMLIDY® (tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015
Medication labelWhy this: Advisory · dailymed-prescription
VEMLIDY is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults and pediatric patients 6 years of age and older and weighing at least 25 kg with compensated liver disease [see Clinical Studies (14)].
- generic_name
- tenofovir alafenamide
- product_names
- tenofovir alafenamide
- ndc
- 61958-2301, 61958-2301-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en